Loading news...
ArriVent Biopharma raised $155M Series B venture round, led by Elena Viboch.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
General CatalystLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Sirona Capital |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$465M
Top Valuation
-
ArriVent Biopharma raised $155M in a Series B round.
The round was announced on 03/27/23.
The round was led by Elena Viboch, James Healy.